Abstract
Background Progressive hypoxemia is the predominant mode of deterioration in COVID-19. Among hypoxemia measures, the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (P/F ratio) has optimal construct validity but poor availability because it requires arterial blood sampling. Pulse oximetry reports oxygenation continuously, but occult hypoxemia can occur in Black patients because the technique is affected by skin color. Oxygen dissociation curves allow non-invasive estimation of P/F ratios (ePFR) but this approach remains unproven.
Research Question Can ePFRs measure overt and occult hypoxemia?
Study Design and methods We retrospectively studied COVID-19 hospital encounters (n=5319) at two academic centers (University of Virginia [UVA] and Emory University). We measured primary outcomes (death or ICU transfer within 24 hours), ePFR, conventional hypoxemia measures, baseline predictors (age, sex, race, comorbidity), and acute predictors (National Early Warning Score (NEWS) and Sepsis-3). We updated predictors every 15 minutes. We assessed predictive validity using adjusted odds ratios (AOR) and area under receiver operating characteristics curves (AUROC). We quantified disparities (Black vs non-Black) in empirical cumulative distributions using the Kolmogorov-Smirnov (K-S) two-sample test.
Results Overt hypoxemia (low ePFR) predicted bad outcomes (AOR for a 100-point ePFR drop: 2.7 [UVA]; 1.7 [Emory]; p<0.01) with better discrimination (AUROC: 0.76 [UVA]; 0.71 [Emory]) than NEWS (AUROC: 0.70 [UVA]; 0.70 [Emory]) or Sepsis-3 (AUROC: 0.68 [UVA]; 0.65 [Emory]). We found racial differences consistent with occult hypoxemia. Black patients had better apparent oxygenation (K-S distance: 0.17 [both sites]; p<0.01) but, for comparable ePFRs, worse outcomes than other patients (AOR: 2.2 [UVA]; 1.2 [Emory], p<0.01).
Interpretation The ePFR was a valid measure of overt hypoxemia. In COVID-19, it may outperform multi-organ dysfunction models like NEWS and Sepsis-3. By accounting for biased oximetry as well as clinicians’ real-time responses to it (supplemental oxygen adjustment), ePFRs may enable statistical modelling of racial disparities in outcomes attributable to occult hypoxemia.
Competing Interest Statement
This work was supported by the Manning fund for COVID-19 research. Dr. Moore is supported by the National Institutes of Health (U01AI150508). Dr. Holder is supported by the National Institutes of Health (K23GM37182), and has received speaker and consulting fees from Baxter International and Philips, respectively. Dr. Kamaleswaran was supported by National Institutes of Health (R01GM139967). Dr. Clark is an employee of Nihon Kohden Digital Health Solutions, Irvine CA. Dr. Moorman has equity in Medical Predictive Science Corporation, Charlottesville, VA, and consults for Nihon Kohden Digital Health Solutions, Irvine, CA, with proceeds donated to the University of Virginia Medical Foundation. For the remaining authors, no conflicts were declared.
Funding Statement
This work was supported by the Manning fund for COVID-19 research. Dr. Moore is supported by the National Institutes of Health (U01AI150508). Dr. Holder is supported by the National Institutes of Health (K23GM37182), and has received speaker and consulting fees from Baxter International and Philips, respectively. Dr. Kamaleswaran was supported by National Institutes of Health (R01GM139967). Dr. Clark is an employee of Nihon Kohden Digital Health Solutions, Irvine CA. Dr. Moorman has equity in Medical Predictive Science Corporation, Charlottesville, VA, and consults for Nihon Kohden Digital Health Solutions, Irvine, CA, with proceeds donated to the University of Virginia Medical Foundation. For the remaining authors, no conflicts were declared.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Virginia and Emory Institutional Review Boards approved the study (Protocol 20249 at UVA; STUDY-00000302 at Emory).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding sources and disclosures: This work was supported by the Manning fund for COVID-19 research. Dr. Moore is supported by the National Institutes of Health (U01AI150508). Dr. Holder is supported by the National Institutes of Health (K23GM37182), and has received speaker and consulting fees from Baxter International and Philips, respectively. Dr. Kamaleswaran was supported by National Institutes of Health (R01GM139967). Dr. Clark is an employee of Nihon Kohden Digital Health Solutions, Irvine CA. Dr. Moorman has equity in Medical Predictive Science Corporation, Charlottesville, VA, and consults for Nihon Kohden Digital Health Solutions, Irvine, CA, with proceeds donated to the University of Virginia Medical Foundation. For the remaining authors, no conflicts were declared.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- ABG
- Arterial blood gas
- AOR
- Adjusted odds ratio
- AUROC
- Area under the receiver operating characteristics curve
- CCI
- Charlson comorbidity index
- COVID-19
- Novel coronavirus disease 2019
- ECDF
- Empirical cumulative distribution functions
- ePFR
- Estimated P/F Ratio
- EUH
- Emory University Hospital
- EUH-M
- Emory University Hospital Midtown
- FiO2
- Fraction of inspired oxygen
- ICU
- Intensive care unit
- IRR
- Inter-rater reliability
- K-S
- Kolmogorov-Smirnov
- LPM
- Liters per minute
- NEWS
- National Early Warning Score
- PaO2
- Partial pressure of arterial oxygen
- P/F ratio
- The ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen
- S/F ratio
- The ratio of the oxygen saturation from pulse oximetry to the fraction of inspired oxygen
- SaO2
- Arterial oxygen saturation
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- SOFA
- Sequential Organ Failure Assessment
- SpO2
- Oxygen saturation from pulse oximetry
- TACS
- Toward a COVID-19 Score
- UVA
- University of Virginia